Olanzapine showed a trend toward greater benefit for subjects of older age, although the result was not statistically significant (Fig. 5 d).
← all excerpts
Imipramine and olanzapine block apoE4-catalyzed polymerization of Aβ and show evidence of improving Alzheimer's disease cognition.
1
—
—